LY 267108

LY 267108 Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White Solid

Verwenden

Erythromycin impurity.

LY 267108 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

LY 267108 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Guangzhou PI PI BIOTECH INC	+86-020-81716320 +86-13602409664	Sales@pipitech.com	China	975	55
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19552	58
TargetMol Chemicals Inc.	+1-781-999-5354; +17819995354	marketing@targetmol.com	United States	32435	58
sgtlifesciences pvt ltd	+8617013299288	dj@sgtlifesciences.com	China	12373	58
China National Standard Pharmaceutical Corporation Limited	+8615391658522	overseasales@yongstandards.com	China	11922	58
DAYANG CHEM (HANGZHOU) CO.,LTD	+86-88938639 +86-17705817739	info@dycnchem.com	China	53899	58
Shanghai Scibiotron Pharmaceutical Co., Ltd	+86-16621589600	contact@scibiotron.com	China	5535	58
QUALITY CONTROL SOLUTIONS LTD.	+86-0755-66853366 +86-13670046396	export03@qcsrm.com	China	24342	58
J & K SCIENTIFIC LTD.	18210857532; 18210857532	jkinfo@jkchemical.com	China	94644	76

105882-69-7()Verwandte Suche:

---

• LY 267108
• (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-Methylbutyl]-2,6,8,10,12-pentaMethyl-9-[[3,4,6-trideoxy-3-(diMethylaMino)-β-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one
• 8,9-Anhydropseudo-erythroMycin A-6,9-heMiketal
• (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-12-en-5-one
• NMIWBQUQCOMGHJ-XWVSLMRSSA-N
• Erythromycin EP Impurity F/(2R,3R,6R,7S,8S,9R,10R)-3-((2R,3R)-2,3-dihydroxypentan-2-yl)-9-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-7-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-2,6
• Erythromycin Impurit F:(pseudoerythromycin A enol ether)
• Erythromycin Impurity 15(Erythromycin EP Impurity F)
• Erythromycin Ethyl succinate Impurity F
• 4,13-Dioxabicyclo[8.2.1]tridec-12-en-5-one, 7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl]oxy]-, (2R,3R,6R,7S,8S,9R,10R)-
• Erythromycin Imp F
• Erythromycin EP Impurity F (Pseudo Erythromycin A Enol Ether)
• Erythromycin impurity 06
• Pseudo erythromycin A enol ether, EvoPure
• (2R,3R,6R,7S,8S,9R,10R)-7-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-3-[(1R,2R)-1,2-dihydroxy-1-methylbutyl]-2,6,8,10,12-pentamethyl-9-[[3,4,6-trideoxy-3-(dimethylamino)-β-D- xylohexopyranosyl]oxy]-4,13-dioxabicyclo[8.2.1]tridec-1(12)-en-5- one
• Erythromycin Impurity F(EP)
• 105882-69-7
• Intermediates & Fine Chemicals
• Metabolites & Impurities
• Pharmaceuticals
• Chromatography
• Drugs&Metabolites
• Forensic and Veterinary Standards
• Neat CompoundsAnalytical Standards
• Pharmacology Standards